DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 8Dr. Reddy's Laboratories
02 6Alfred E Tiefenbacher GmbH
03 3Mankind Pharma
04 1#NAME?
05 3Accord healthcare
06 3Adalvo
07 3Alkem Laboratories
08 21Amgen Inc
09 3Amneal Pharmaceuticals
10 2Anabiosis S.A.
11 3Annora Pharma
12 1Apotex Inc
13 4Auro Pharma Inc
14 3Aurobindo Pharma Limited
15 1Avansor Pharma Oy
16 2CLONMEL HLTHCARE
17 5Celgene Corporation
18 4Glenmark Pharmaceuticals
19 3Grindeks AS
20 3Intas Pharmaceuticals
21 4JAMP PHARMA
22 2Krka
23 3MSN Laboratories
24 3Macleods Pharmaceuticals Limited
25 1Noucor
26 1Pharmascience Inc.
27 7STADA Arzneimittel
28 9Sandoz B2B
29 3Shilpa Medicare
30 1Tarbis Farma Sl
31 3Tecnimede
32 5Teva Pharmaceutical Industries
33 8Torrent Pharmaceuticals Limited
34 3Unichem Pharmaceuticals USA, Inc
35 5Zentiva
36 3Zydus Pharmaceuticals
01 1Antic-calc Tablet, Film Coated
02 3Coated Tablet
03 1FCT
04 52Film Coated Tablet
05 3Film Coated Tablet
06 3Oral Solid Dosage Form
07 19TABLET
08 1TABLET, EXTENDED RELEASE;ORAL
09 51TABLET;ORAL
10 3Tablet
11 6Blank
01 2Allowed
02 23Approved
03 11Authorised
04 7Authorized
05 24DISCN
06 6EU Dossier Readiness-Q3 2020
07 3Lead Market Dossiers- Filed
08 1Originator
09 19Prescription
10 19RX
11 28Blank
01 1APO-APREMILAST
02 42APREMILAST
03 4AURO-APREMILAST
04 1Apremilast +Pharma
05 3Apremilast Accord
06 2Apremilast Anabiosis
07 1Apremilast Avansor
08 2Apremilast Clonmel
09 2Apremilast Krka
10 1Apremilast Noucor
11 2Apremilast Reddy
12 5Apremilast Sandoz
13 3Apremilast Stada
14 2Apremilast Stada Arzneimittel Ag
15 2Apremilast Stada Nordic
16 1Apremilast Tarbis
17 2Apremilast Teva
18 2Apremilast Torrent
19 2Apremilast Zentiva
20 1GLN-APREMILAST
21 4JAMP APREMILAST
22 13OTEZLA
23 1OTEZLA XR
24 11Otezla
25 1Otezla 30mg
26 1PMS-APREMILAST
27 1Phomilot
28 4SANDOZ APREMILAST
29 2Supota
30 24Blank
01 2Australia
02 19Canada
03 3Czech Republic
04 6Germany
05 9India
06 3Latvia
07 11Malta
08 2Norway
09 3Portugal
10 1South Africa
11 7Spain
12 23Sweden
13 2Switzerland
14 52USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : APREMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2023-07-14
Application Number : 211756
Regulatory Info : DISCN
Registration Country : USA
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
Regulatory Info : RX
Registration Country : USA
Brand Name : APREMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2024-02-07
Application Number : 211734
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : APREMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2023-07-14
Application Number : 211756
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : APREMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2023-07-14
Application Number : 211756
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Authorised
Registration Country : Malta
Brand Name : Apremilast Reddy
Dosage Form : Film Coated Tablet
Dosage Strength : 30MG
Packaging :
Approval Date : 2025-06-20
Application Number :
Regulatory Info : Authorised
Registration Country : Malta
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Authorised
Registration Country : Malta
Brand Name : Apremilast Reddy
Dosage Form : Film Coated Tablet
Dosage Strength : 10MG; 20MG; 30MG
Packaging :
Approval Date : 2025-06-20
Application Number :
Regulatory Info : Authorised
Registration Country : Malta
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
Regulatory Info : RX
Registration Country : USA
Brand Name : APREMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2024-02-07
Application Number : 211734
Regulatory Info : RX
Registration Country : USA
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
Regulatory Info : RX
Registration Country : USA
Brand Name : APREMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2024-02-07
Application Number : 211734
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OTEZLA
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2014-03-21
Application Number : 205437
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OTEZLA
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2014-03-21
Application Number : 205437
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OTEZLA
Dosage Form : TABLET;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2014-03-21
Application Number : 205437
Regulatory Info : RX
Registration Country : USA
